Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation

Cellular and Molecular Immunology

Volumn 10, Issue 4, 2013, Pages 360-372

  Arunkumar, Nandini ^a   Liu, Chaohong ^a   Hang, Haiying ^b   Song, Wenxia ^a  

^a Bldg 142   (United States)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

apoptosis; lymphoma B cells; NF B; Toll like receptor

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; FAS ANTIGEN; FAS LIGAND; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN BCL XL; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; DRUG STRUCTURE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MOUSE; NONHUMAN; SPLEEN CELL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BCL-X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; FAS LIGAND PROTEIN; HUMANS; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-MYC; TOLL-LIKE RECEPTOR 9; TRANSCRIPTIONAL ACTIVATION;

EID: 84879916108     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.14     Document Type: Article

References (85)

1. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20: 197-216. (Pubitemid 34293424)
2. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2(8): 675-680. (Pubitemid 32747155)
3. Cardon LR, Burge C, Clayton DA, Karlin S. Pervasive Cp Gsuppression in animal mitochondrial genomes. Proc Natl Acad Sci USA 1994; 91(9): 3799-3803. (Pubitemid 24139519)
4. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R et al. Cp G motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374(6522): 546-549.
5. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to Cp G oligodeoxynucleotides. JImmunol 2002; 168(9): 4531-4537. (Pubitemid 34441357)
6. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5(10): 987-995. (Pubitemid 41057715)
7. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial Cp G-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002; 32(7): 1958-1968. (Pubitemid 34814552)
8. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4(7): 499-511. (Pubitemid 38931765)
9. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H. Immune cell activation by bacterial Cp G-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 2000; 192(4): 595-600. (Pubitemid 30666261)
10. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412(6844): 346-351. (Pubitemid 32694385)
11. Yi AK, Yoon JG, Krieg AM. Convergence of Cp G DNA-and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases. Int Immunol 2003; 15(5): 577-591. (Pubitemid 36519396)
12. Hartmann G, Krieg AM. Mechanismandfunctionofanewlyidentified Cp G DNA motif in human primary B cells. JImmunol 2000; 164(2): 944-953.
13. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. Cp G motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 1996; 93(7): 2879-2883. (Pubitemid 26116242)
14. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. Cp G oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998; 160(12): 5898-5906. (Pubitemid 28298049)
15. Yi AK, Hornbeck P, Lafrenz DE, Krieg AM. Cp G DNArescueof murine B lymphoma cells from anti-Ig M-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J Immunol 1996; 157(11): 4918-4925. (Pubitemid 126449568)
16. Yi AK, Peckham DW, Ashman RF, Krieg AM. Cp G DNArescues Bcells from apoptosis byactivating NFkappa Band preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 1999; 11(12): 2015-2024. (Pubitemid 30009161)
17. Haase R, Kirschning CJ, Sing A, Schrottner P, Fukase K, Kusumoto S et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol 2003; 171(8): 4294-4303. (Pubitemid 37238708)
18. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999; 285(5428): 736-739.
19. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006; 176(8): 4894-4901.
20. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immuneresponses. Nat Rev Immunol 2005; 5(6): 446-458. (Pubitemid 40835033)
21. Krieg AM. Antitumor applications of stimulating Toll-like receptor 9 withCp Goligodeoxynucleotides. Curr Oncol Rep 2004; 6(2): 88-95. (Pubitemid 38898835)
22. Ballas ZK, Krieg AM, Warren T, Rasmussen W, Davis HL, Waldschmidt M et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct Cp G motifs. J Immunol 2001; 167(9): 4878-4886. (Pubitemid 33009716)
23. Baines J, Celis E. Immune-mediated tumor regression induced by Cp G-containing oligodeoxynucleotides. Clin Cancer Res 2003; 9(7): 2693-2700. (Pubitemid 36842115)
24. Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR et al. Toll-like receptor 9 signaling by Cp G-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 2010; 115(24): 5041-5052.
25. Jahrsdorfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK et al. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells. J Leukoc Biol 2005; 77(3): 378-387. (Pubitemid 40289568)
26. Haughton G, Arnold LW, Bishop GA, Mercolino TJ. The CH series of murine B cell lymphomas: neoplastic analoguesof Ly-1+ normal B cells. Immunol Rev 1986;93:35-51. (Pubitemid 17171498)
27. Jelachich ML, Grusby MJ, Clark D, Tasch D, Margoliash E, Pierce SK. Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation. Proc Natl Acad Sci USA 1984; 81(17): 5537-5541. (Pubitemid 14000518)
28. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T et al. Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation. Bioorg Med Chem 2003; 11(3): 383-391. (Pubitemid 36051028)
29. Baader E, Toloczko A, Fuchs U, Schmid I, Beltinger C, Ehrhardt H et al. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects. Cancer Res 2005; 65(17): 7888-7895. (Pubitemid 41297266)
30. Pennell CA, Arnold LW, Lutz PM, Lo Cascio NJ, Willoughby PB, Haughton G. Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci USA 1985; 82(11): 3799-3803. (Pubitemid 15246440)
31. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 93: 2239.
32. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998;31(1): 1-9. (Pubitemid 28050057)
33. Fadok VA, Laszlo DJ, Noble PW, Weinstein L, Riches DW, Henson PM. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol 1993; 151(8): 4274-4285. (Pubitemid 23298761)
34. Kelly PN, Grabow S, Delbridge AR, Strasser A, Adams JM. Endogenous Bcl-xL isessential for Myc-driven lymphomagenesis in mice. Blood 2011; 118(24): 6380-6386.
35. Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclearfactor-kappaB. Nat Rev Immunol 2005; 5(6): 435-445.
36. Dal Porto JM, Gauld SB, Merrell KT, Mills D, Pugh-Bernard AE, Cambier J. B cell antigen receptor signaling 101. Mol Immunol 2004; 41(6-7): 599-613. (Pubitemid 38824617)
37. Adhikary S, Eilers M. Transcriptionalregulationandtransformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6(8): 635-645.
38. Into T, Kiura K, Yasuda M, Kataoka H, Inoue N, Hasebe A et al. Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membranelipoproteins of Mycoplasma fermentans inducesapoptoticcell death after NF-kappa B activation. Cell Microbiol 2004; 6(2): 187-199. (Pubitemid 38111599)
39. Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, Hacker G et al. Signalingofapoptosisthrough TLRscritically involvestoll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not My D88, in bacteria-infected murine macrophages. J Immunol 2004; 173(5): 3320-3328. (Pubitemid 39142041)
40. Mercolino TJ, Arnold LW, Haughton G. Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific forerythrocyte membranes. J Exp Med 1986; 163(1): 155-165. (Pubitemid 16189517)
41. Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancyof anti-self B cells. Blood 1996; 87(7): 2615-2620. (Pubitemid 26102209)
42. Sthoeger ZM. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 1989; 169: 255.
43. Cooper MR, Cohen HJ, Huntley CC, Waite BM, Spees L, Spurr CL. A monoclonal Ig M with antibodylike specificity for phospholipids in a patient with lymphoma. Blood 1974; 43(4): 493-504.
44. Gelmann EP, Psallidopoulos MC, Papas TS, Dalla-Favera R. Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin mu locus in a Burkitt lymphoma. Nature 1983; 306(5945): 799-803. (Pubitemid 14206049)
45. Schlaifer D, March M, Krajewski S, Laurent G, Pris J, Delsol G et al. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 1995; 85(10): 2671-2674.
46. Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K et al. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol 2012; 91(6): 863-873.
47. Acosta-Rodriguez EV, Craxton A, Hendricks DW, Merino MC, Montes CL, Clark EA et al. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur J Immunol 2007; 37(4): 990-1000. (Pubitemid 46925336)
48. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011;470(7332): 115-119.
49. Choi JW, Kim Y, Lee JH, Kim YS. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma. Hum Pathol 2013; in press.
50. Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 2006; 1757(9-10): 1301-1311. (Pubitemid 44442128)
51. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69: 217.
52. Duyao MP, Kessler DJ, Spicer DB, Bartholomew C, Cleveland JL, Siekevitz M et al. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J Biol Chem 1992; 267(23): 16288-16291.
53. Grumont RJ, Strasser A, Gerondakis S. B cell growth iscontrolled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol Cell 2002; 10(6): 1283-1294. (Pubitemid 36050871)
54. Radhakrishnan SK, Kamalakaran S. Pro-apoptoticroleof NF-kappaB: implications for cancer therapy. Biochim Biophys Acta 2006; 1766(1): 53-62. (Pubitemid 44175630)
55. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441(7092): 431-436. (Pubitemid 44050137)
56. Prendes M, Zheng Y, Beg AA. Regulationofdeveloping Bcell survival by Rel A-containing NF-kappa B complexes. J Immunol 2003; 171(8): 3963-3969.
57. Rui L, Goodnow CC. Lymphoma and the control of B cell growth and differentiation. Curr Mol Med 2006; 6(3): 291-308.
58. Kelly K, Cochran BH, Stiles CD, Leder P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983; 35(3 Pt 2): 603-610. (Pubitemid 14168364)
59. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-mycexpressioninan IL-3-dependentmyeloidcell linesuppressescell cycle arrest and accelerates apoptosis. Oncogene 1991; 6(10): 1915-1922. (Pubitemid 21924028)
60. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69(1): 119-128.
61. Thompson EB. The many roles of c-Myc in apoptosis. Annu Rev Physiol 1998; 60: 575-600. (Pubitemid 28157887)
62. Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI et al. Inductionof TNF-sensitivecellularphenotype byc-Mycinvolves p53 and impaired NF-kappaB activation. Embo J 1997; 16(24): 7382-7392. (Pubitemid 28010498)
63. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008; 22(20): 2755-2766.
64. Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res 2011; 21(2): 223-244.
65. Meyer N, Kim SS, Penn LZ. The Oscar-worthyroleof Myc inapoptosis. Semin Cancer Biol 2006; 16(4): 275-287.
66. Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003; 22(56): 9007-9021. (Pubitemid 38121701)
67. You Z, Madrid LV, Saims D, Sedivy J, Wang CY. c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation. J Biol Chem 2002; 277(39): 36671-36677.
68. deAlboran IM, Baena E, Martinez AC. c-Myc-deficient B lymphocytes areresistanttospontaneousand inducedcell death. Cell Death Differ 2004; 11(1): 61-68. (Pubitemid 38111373)
69. Lu B, Wang L, Medan D, Toledo D, Huang C, Chen F et al. Regulation of Fas (CD95)-induced apoptosis bynuclearfactor-kappaBand tumor necrosis factor-alpha in macrophages. Am J Physiol Cell Physiol 2002; 283(3): C831-C838. (Pubitemid 34920316)
70. Dudley E, Hornung F, Zheng L, Scherer D, Ballard D, Lenardo M. NF-kappaB regulates Fas/APO-1/CD95-and TCR-mediated apoptosis of T lymphocytes. Eur J Immunol 1999; 29(3): 878-886. (Pubitemid 29119067)
71. Carey GB, Donjerkovic D, Mueller CM, Liu S, Hinshaw JA, Tonnetti L et al. B-cell receptor and Fas-mediated signals for life and death. Immunol Rev 2000; 176: 105-115.
72. Boyd AW, Schrader JW. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. JImmunol 1981; 126(6): 2466-2469. (Pubitemid 11072886)
73. Ralph P. Functional subsets of murine and human B lymphocyte cell lines. Immunol Rev 1979;48: 107-121. (Pubitemid 11119735)
74. Yi AK, Krieg AM. Cp G DNA rescue from anti-Ig M-inducedWEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. JImmunol 1998; 160(3): 1240-1245. (Pubitemid 28093421)
75. Levine RA, Mc Cormack JE, Buckler A, Sonenshein GE. Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells. Mol Cell Biol 1986; 6(11): 4112-4116.
76. Macfarlane DE, Manzel L, Krieg AM. Unmethylated Cp G-containing oligodeoxynucleotides inhibitapoptosis in WEHI 231 Blymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step. Immunology 1997; 91(4): 586-593. (Pubitemid 27312342)
77. Lundy SK. Killer B lymphocytes: the evidence and the potential. Inflamm Res 2009; 58(7): 345-357.
78. Lee KG, Xu S, Wong ET, Tergaonkar V, Lam KP. Bruton's tyrosine kinase separately regulates NFkappa B p65Rel A activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells. J Biol Chem 2008; 283(17): 11189-11198.
79. Walczynski J, Lyons S, Jones N, Breitwieser W. Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2. Oncogene 2013; in press.
80. Gururajan M, Chui R, Karuppannan AK, Ke J, Jennings CD, Bondada S. c-Jun N-terminal kinase(JNK) isrequiredforsurvival and proliferationof B-lymphomacells. Blood 2005; 106(4): 1382-1391.
81. Lizundia R, Chaussepied M, Huerre M, Werling D, Di Santo JP, Langsley G. c-Jun NH2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria. Cancer Res 2006; 66(12): 6105-6110.
82. Wiesner DA, Kilkus JP, Gottschalk AR, Quintans J, Dawson G. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slowformationofceramidefromsphingomyelinand isblocked bybcl-XL. J Biol Chem 1997; 272(15): 9868-9876. (Pubitemid 27171654)
83. Chmura SJ, Nodzenski E, Crane MA, Virudachalam S, Hallahan DE, Weichselbaum RR et al. Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231. Adv Exp Med Biol 1996; 406: 39-55. (Pubitemid 26357340)
84. Taha TA, Mullen TD, Obeid LM. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 2006; 1758(12): 2027-2036. (Pubitemid 44879375)
85. Carpinteiro A, Dumitru C, Schenck M, Gulbins E. Ceramide-induced cell death in malignantcells. Cancer Lett 2008; 264(1): 1-10.